Clinical Trials Browser

Phase 1/2 × Advanced Pancreatic Cancer × Nivolumab × Clear all

NCT05162118 2022-03-09

Clinical Study of VG161 in Combination With Nivolumab in Subjects With Advanced Pancreatic Cancer

Phase 1/2 Unknown

Gastrointestinal

Advanced Pancreatic Cancer